𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biologic basis and evolving role of aromatase inhibitors in the management of invasive carcinoma of the breast

✍ Scribed by Henry M. Kuerer; Aman U. Buzdar; S. Eva Singletary

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
369 KB
Volume
77
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The role of aromatase inhibitors in the
The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma : The M. D. Anderson Cancer Center evidence-based approach
✍ Paolo Morandi; Roman Rouzier; Kadri Altundag; Aman U. Buzdar; Richard L. Theriau πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 98 KB

## Abstract ## BACKGROUND The authors examined the published evidence on the use of aromatase inhibitors (AIs) in the adjuvant setting in postmenopausal, hormone receptor–positive patients, and they provide recommendations for clinical management in 3 different situations: newly diagnosed women, w

Clinical use of aromatase inhibitors in
Clinical use of aromatase inhibitors in the treatment of breast cancers
✍ Andrea Manni πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 388 KB πŸ‘ 1 views

Estrogens are the major hormones supporting the growth of human breast cancer. Aromatization of androgen precursors in peripheral tissues, including the breast cancer itself, is the major source of estrogens in postmenopausal women. Therefore, inhibition of the aromatase enzyme offers an effective m